Effects of pyridoxine alpha-ketoglutarate on blood glucose and lactate in type I and II diabetics

N. Passariello, F. Fici, D. Giugliano, A. Ceriello, P. Dello Russo, S. Sgambato

Research output: Contribution to journalArticle

Abstract

The administration of pyridoxine-alpha-ketoglutarate (PAK) to type I and II diabetics previously treated with insulin and phenformin, reduces blood glucose, HbA1, and blood levels of lactate and pyruvate. The results of this double-blind clinical trial showed that PAK is advantageous for improving certain metabolic aspects in diabetics.

Original languageEnglish
Pages (from-to)252-256
Number of pages5
JournalInternational Journal of Clinical Pharmacology Therapy and Toxicology
Volume21
Issue number5
Publication statusPublished - 1983

    Fingerprint

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology (medical)

Cite this